Raul Malo's Colon Cancer and Leptomeningeal Disease

What Raul Malo shared

Raul Malo, lead singer of The Mavericks, disclosed in June 2024 that he was receiving treatment for colon cancer after abnormal findings during a routine physical. In September 2025, he said the cancer had progressed to leptomeningeal disease, involving membranes around the brain and spinal cord. Malo died in December 2025 at age 60.

His public updates joined two topics readers may encounter separately: colorectal-cancer screening and a rare, serious complication of advanced cancer. Screening can prevent some colorectal cancers or find them earlier, but it cannot prevent every diagnosis or guarantee that cancer will never spread.

Colon cancer, screening, and symptoms

Colorectal cancer begins in the colon or rectum and often develops from polyps. Screening can find and remove some precancerous polyps. Options include stool-based tests, colonoscopy, and other structural tests; the best choice depends on age, risk, access, and preferences. A positive non-colonoscopy test generally needs a timely colonoscopy to complete the screening process.

Possible symptoms include blood in or on the stool, a lasting change in bowel habits, abdominal pain, unexplained anemia, fatigue, or weight loss. These findings have many causes. Symptoms need diagnostic evaluation and should not wait for the next routine screening test.

Risk is associated with age, family history, inherited syndromes, inflammatory bowel disease, tobacco, alcohol, excess body weight, and other factors. Physical activity, avoiding tobacco, limiting alcohol, and a healthy eating pattern may lower risk, but a diagnosis is never proof that someone failed at prevention.

What leptomeningeal disease means

Leptomeningeal disease occurs when cancer cells reach the fluid and membranes surrounding the brain and spinal cord. It remains metastatic colon cancer if the cells began in the colon; it is not a new primary brain cancer.

Symptoms can vary and may include new severe headaches, nausea, confusion, weakness, numbness, balance changes, seizures, vision or hearing changes, or bowel and bladder problems. New neurologic symptoms in someone with cancer can be urgent. Evaluation may include neurologic examination, contrast MRI of the brain and spine, and analysis of cerebrospinal fluid.

Treatment depends on the original cancer, molecular findings, symptoms, previous therapies, and goals. Options may include systemic treatment that reaches the central nervous system, treatment delivered into spinal fluid, radiation to symptomatic areas, steroids, procedures, and supportive or palliative care.

What this story cannot tell you

• Malo's course does not predict another person's colon cancer or leptomeningeal disease.
• Screening lowers risk but cannot guarantee prevention or early detection.
• Ordinary headaches or balance problems usually have causes other than leptomeningeal disease.
• A neurologic symptom cannot establish cancer spread without medical evaluation.

Questions patients can ask

• Am I due for colorectal screening, and which test fits me?
• Does a symptom require diagnostic colonoscopy rather than a screening test?
• If cancer has spread, were pathology and molecular results reviewed again?
• Which new neurologic symptoms require an urgent call or emergency assessment?

How this article was prepared

Prepared by Cancer Explained's AI-assisted editorial system and checked against public reporting and official NCI information. It has not been reviewed by a healthcare professional unless a named reviewer is shown.

Found an error or wording that feels unsafe or unclear? Report it here.